Used in pharmaceutical research as a key intermediate in the synthesis of tyrosine kinase inhibitors, particularly targeting EGFR (epidermal growth factor receptor) for potential cancer treatments. Its structure supports high binding affinity to mutant forms of the receptor, making it valuable in developing targeted therapies for non-small cell lung cancer. Also investigated for improved selectivity and reduced resistance in next-generation oncology drugs.